Legal Representation
Attorney
Jennifer D. Arkowitz, Esq.
USPTO Deadlines
Application History
26 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Sep 20, 2010 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Sep 20, 2010 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Feb 24, 2010 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Feb 18, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 18, 2010 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Sep 14, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Sep 14, 2009 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Aug 18, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 18, 2009 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Feb 19, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 19, 2009 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Feb 19, 2009 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Aug 21, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 21, 2008 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Aug 21, 2008 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Feb 8, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 8, 2008 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Feb 8, 2008 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Aug 21, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 29, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 9, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Mar 30, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
Mar 30, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Mar 7, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 7, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 27, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemicals relating to drug performance and/or drug delivery performance for research use and manufacturing in the biotechnical, biomedical and pharmaceutical industries
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as diabetes, infections, cancers, inflammations, respiratory and pulmonary conditions, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical devices, namely, medical apparatus in the nature of a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles, and inhaler devices, sold empty, used to introduce medication into the respiratory system as fine liquid mist for the treatment of respiratory and pulmonary conditions
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Technical consulting and research services; namely, providing consultation, research and development services relating to drug performance and/or drug delivery performance to others in the biotechnical, biomedical and pharmaceutical fields
First Use Anywhere:
May 10, 2006
First Use in Commerce:
May 10, 2006
Classification
International Classes
001
005
010
042